1ANDRAWISS M. Cervical cancer vaccines available in 2007 [J]. Drug Disc Today, 2005, 10 (14) : 949-950. 被引量：1
2WRIGHT T C J R, COX J T, MASSAD L S, et al. 2001 Consensus guidelines for the managerment of wemen with cervical intraepithelial neoplasia [ J ]. J Low Genit Tract Dis, 2003, 7 (3) : 295-304. 被引量：1
3TARWRIEYI F. Perceptions and barriers to cenieal caneer screening in a rural district of mutoko. Mashonaland East Province. Zimbabwe[J]. Cent AfrJ Med, 2005, 51 (11-12) : 120-122. 被引量：1
6METYLER L, AHMED-EBBIARY N, SCHOLLMEYER T. Laparoscopic hysterectomy: Challenges and limitations [ J ] . Minim Invasive Therallied Technol, 2005, 14 (3) : 145-159. 被引量：1
7BANSAL M, AUSTIN R M, ZHAO C. High-risk HPV DNA detected in less than 2% of over 25, 000 cytology negative imaged liquid-based Pap test samples from women 30 and older[J]. Gynecol Oncol, 2009, 115 (2) : 257-261. 被引量：1
8DENNY L A, WRIGHT T C J R. Human papillomavirus testing and screening [ J]. Best Pract Res Clin Obstet Gynagecol, 2005, 19 (4): 501-515. 被引量：1
9MASUMOTO N, FUJII T, ISHIKAWA M, et al. Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women : study of 881 outpatients [J]. Gynecol Oncol, 2004, 94 (2): 509-514. 被引量：1
10BASEMAN J G, KULASINGAM S L, HARRIS T G, et al. Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning chnics in the United States [ J ]. Am J Obstet Gynecol, 2008, 199 (1) : 26. e1-8. 被引量：1
